As mentioned earlier, c-KIT is also expressed in a subset of human CRC cells [5], which endows mTOR inhibitor with the possibility of inducing autophagic degradation of c-KIT in this subset of human CRC cells. This evidence concerns the gene KIT and colorectal carcinoma.